IL4I1 and neoplasm: Further correlation analysis using the TCGA database on TP53-mutant EC samples revealed that IL4I1 expression was significantly positively correlated with tryptophan metabolism and tumor inflammation features, while exhibiting a negative correlation with tumor mutational burden (TMB) (Figure 6D–F).